and reporting the incidence rates of new-onset DM in both arms. To be consistent with other large meta-analyses and to provide robust estimates, we excluded trials with follow-up 1 year and including
and reporting the incidence rates of new-onset DM in both arms. To be consistent with other large meta-analyses and to provide robust estimates, we excluded trials with follow-up 1 year and including <1,000 patients.